Patent · US Active

Vasopressin V1a antagonists

US8202858B2 · kind B2 · utility

3Cited by
8References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 24, 2005
Grant dateJun 19, 2012
Priority date
Expiry dateJul 5, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention concerns compounds inter alia according to general formula 1a. Compounds according to the invention are vasopressin V1a receptor antagonists. Pharmaceutical compositions of the compounds are useful as treatment of dysmenorrhoea.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.